Sorrento Therapeutics (NASDAQ:SRNE) jumps 58% premarket on robust volume in reaction to a non-binding proposal from an unnamed private equity fund to acquire all of its outstanding shares at $7 per share. The board is reviewing the proposal.
Yesterday’s close was $3.41.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.